- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MOBILE-HEALTH NETWORK SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 14:38 | Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference, May 21-22, and Virtual Tech Conference, June 3-5 | 169 | Newsfile | Singapore, Singapore--(Newsfile Corp. - May 15, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
| 05.05. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.04. | Mobile-health Network Solutions Intends To Acquire Lifepack, Expanding into Indonesia's Growing Healthcare Market | 221 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 30, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
| 29.04. | Mobile-health Network Solutions Wins Cloud-Healthcare Technology Award at SBR Technology Excellence Awards 2025 | 243 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 29, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth... ► Artikel lesen | |
| 26.03. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.03. | Mobile-health Network Solutions files to sell 3.34M Class A ordinary shares | 2 | Seeking Alpha | ||
| 21.03. | Mobile-health Network Solutions - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 06.03. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | Centurion One Capital Corp.: Mobile-health Network Solutions to Present at Centurion One Capital 8th Annual Growth Conference | 256 | Newsfile | Singapore, Singapore--(Newsfile Corp. - February 27, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a pioneering MedTech company dedicated to enhancing human connection... ► Artikel lesen | |
| 19.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 04.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.01. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.12.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.12.24 | Mobile-health Network Solutions Launches ManaSocial, New Digital Healthcare Engagement Platform Expected to Accelerate Growth | 3 | GlobeNewswire (USA) | ||
| 23.10.24 | Mobile-health Network Solutions Reports 77 Percent Revenue Increase for Fiscal Year 2024 | 271 | GlobeNewswire (Europe) | SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the fiscal... ► Artikel lesen | |
| 15.10.24 | Mobile-health Network Solutions Announces Participation in the LD Micro Main Event XVII | 272 | Newsfile | Singapore, Singapore--(Newsfile Corp. - October 15, 2024) - Mobile-health Network Solutions (NASDAQ: MNDR), a leading Asia-Pacific telehealth provider, announced today that it will be presenting at... ► Artikel lesen | |
| 21.09.24 | Mobile-health Network Solutions Delinquency Notification Letter From Nasdaq | 354 | GlobeNewswire (Europe) | SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received... ► Artikel lesen | |
| 19.06.24 | Mobile-health Network Solutions Pte Ltd: Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day | 557 | JCN Newswire | SINGAPORE, June 19, 2024 - (NewMediaWire) - Mobile-health Network Solutions ['MaNaDr'](Nasdaq: MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight... ► Artikel lesen | |
| 21.05.24 | Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 2024 | 308 | GlobeNewswire (Europe) | SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,129 | -5,15 % | Sernova Biotherapeutics Inc: Sernova talks interim data from Cell Pouch trial | ||
| ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,802 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,244 | -21,29 % | Co-Diagnostics GAAP EPS of -$0.24 beats by $0.03, revenue of $0.05M misses by $0.14M | ||
| CYTOSORBENTS | 0,697 | -6,82 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,450 | -0,49 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,465 | -2,52 % | VolitionRX Q1 2025 Earnings Preview | ||
| EKSO BIONICS | 0,388 | -3,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Accepted into NVIDIA Connect Program | ||
| IMUNON | 0,540 | -1,82 % | Imunon, Inc.: IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 | Company's PlaCCine® technology platform demonstrates better durability and other advantages compared to mRNA vaccines Results further validate PlaCCine as a novel vaccine platform with potential applications... ► Artikel lesen | |
| BEYOND AIR | 0,170 | +3,03 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| NOVACYT | 0,469 | +0,11 % | Novacyt announces AGM scheduled for June 19, 2025 | ||
| AROVELLA THERAPEUTICS | 0,042 | 0,00 % | Biocurious: With its 'molecular Lego' approach, Arovella is building hope for cancer patients one brick at a time |
Das Unternehmen MOBILE-HEALTH NETWORK SOLUTIONS kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -5,80 % bei einem Aktienkurs von 1,300 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOBILE-HEALTH NETWORK SOLUTIONS finden Sie auf Wallstreet Online.